Erythromycin
- Generic Name
- Erythromycin
- Brand Names
- Aktipak, Apo-Erythro-S, Benzamycin, E.E.S., Ery, Ery-tab, Erygel, Eryped, Erythro, Erythrocin, Erythrocin Stearate
- Drug Type
- Small Molecule
- Chemical Formula
- C37H67NO13
- CAS Number
- 114-07-8
- Unique Ingredient Identifier
- 63937KV33D
- Background
Erythromycin is a bacteriostatic antibiotic drug produced by a strain of Saccharopolyspora erythraea (formerly Streptomyces erythraeus) and belongs to the macrolide group of antibiotics which consists of Azithromycin, Clarithromycin, Spiramycin and others. It was originally discovered in 1952. Erythromycin is widely used for treating a variety of infections,...
- Indication
Erythromycin is indicated in the treatment of infections caused by susceptible strains of various bacteria. The indications for erythromycin have been summarized by body system below:
Respiratory infections
...
- Associated Conditions
- Acne, Acne Vulgaris, Acute Otitis Media caused by Haemophilus Influenzae, Acute pelvic inflammatory disease caused by Neisseria Gonorrheae Infection, Bacterial Infections, Chancroid, Chlamydia Trachomatis, Chlamydial ophthalmia neonatorum, Community Acquired Pneumonia (CAP), Diphtheria, Erythrasma, Gastroparesis, Granuloma Inguinale, Intestinal amebiasis caused by entamoeba histolytica, Legionella Pneumophila Infections, Listeria infection, Lower Respiratory Tract Infection (LRTI), Lymphogranuloma Venereum, Nongonococcal urethritis, Ophthalmia neonatorum (gonococcal), Pertussis, Postoperative Infections, Primary Syphilis, Respiratory Tract Infections (RTI), Skin and skin structure infections, Staphylococcal Skin Infections, Syphilis, Upper Respiratory Tract Infection, Ureaplasma urethritis, Whooping Cough, Inflammatory papular lesions, Mild Acne vulgaris, Moderate Acne vulgaris, Predominant skin comedones, papules and pustules, Prophylaxis of Rheumatic fever, Pustular lesions, Skin and subcutaneous tissue bacterial infections caused by streptococcus pyogenes, Superficial ocular infections
- Associated Therapies
- -
Randomized Control Trial Comparing Prokinetics and Their Influence on Endoscopy Outcomes for Upper GI Bleed.
- Conditions
- Interventions
- First Posted Date
- 2013-12-20
- Last Posted Date
- 2021-03-04
- Target Recruit Count
- 4
- Registration Number
- NCT02017379
- Locations
- 🇺🇸
Texas Tech University Health Science Center, El Paso, Texas, United States
Erythromycin in Parkinson's Disease
- Conditions
- Interventions
- First Posted Date
- 2013-12-09
- Last Posted Date
- 2017-02-03
- Lead Sponsor
- Virginia Commonwealth University
- Target Recruit Count
- 18
- Registration Number
- NCT02005029
- Locations
- 🇺🇸
Virginia Commonwealth University Parkinson's Center, Richmond, Virginia, United States
Treatment of Antenatal Chlamydia Infection
- Conditions
- Interventions
- First Posted Date
- 2013-09-19
- Last Posted Date
- 2014-03-27
- Lead Sponsor
- Obafemi Awolowo University Teaching Hospital
- Target Recruit Count
- 220
- Registration Number
- NCT01946256
- Locations
- 🇳🇬
Obafemi Awolowo University Teaching Hospitals Complex, Ile Ife, Ile Ife, Imesi Ile, Nigeria
Study of Erythromycin in GER-Associated Apnea of the Newborn
- Conditions
- Interventions
- First Posted Date
- 2013-04-05
- Last Posted Date
- 2013-04-05
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 40
- Registration Number
- NCT01825473
- Locations
- 🇺🇸
University of Virginia Children's Hospital, Charlottesville, Virginia, United States
Erythromycin Versus Gastric Lavage to Improve Quality of Endoscopy in Patients With Upper Gastrointestinal Bleeding
- Conditions
- Interventions
- First Posted Date
- 2012-10-30
- Last Posted Date
- 2015-10-08
- Lead Sponsor
- Hospital Universitari de Bellvitge
- Target Recruit Count
- 122
- Registration Number
- NCT01716572
- Locations
- 🇪🇸
Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain
Comparison of Two Preemptive Treatment Strategies of Panitumumab Mediated Skin Toxicity and Assessment of QoL in Patient With Ras-wt Colorectal Cancer
- Conditions
- Interventions
- First Posted Date
- 2012-08-20
- Last Posted Date
- 2016-04-19
- Lead Sponsor
- AIO-Studien-gGmbH
- Target Recruit Count
- 88
- Registration Number
- NCT01668498
- Locations
- 🇩🇪
Universitätsklinikum Mannheim, III. Medizinische Klinik, Mannheim, Germany
Effect of Erythromycin Before Endoscopy of Patients With Subtotal Gastrectomy (STG), High Risk of Gastric Stasis
- First Posted Date
- 2012-08-08
- Last Posted Date
- 2013-02-21
- Lead Sponsor
- The Catholic University of Korea
- Target Recruit Count
- 114
- Registration Number
- NCT01659619
- Locations
- 🇰🇷
Seoul St. Mary hospital, Seoul, Korea, Republic of
Use of Prokinetics in Early Enteral Feeding in Preterm Infants
- Conditions
- Interventions
- First Posted Date
- 2012-04-03
- Last Posted Date
- 2022-11-21
- Lead Sponsor
- East Tennessee State University
- Registration Number
- NCT01569633
- Locations
- 🇺🇸
East Tennessee State University, Johnson City, Tennessee, United States
Erythromycin Versus Azithromycin in Preterm Premature Rupture of Membranes
- Conditions
- Interventions
- First Posted Date
- 2012-03-16
- Last Posted Date
- 2024-10-14
- Lead Sponsor
- Indiana University
- Registration Number
- NCT01556334
- Locations
- 🇺🇸
Indiana University School of Medicine, Indianapolis, Indiana, United States
Comparative Study in the Efficacy of Topical Besifloxocin With Erythromycin for the Management of Acute Blepharitis
- First Posted Date
- 2011-11-23
- Last Posted Date
- 2013-12-19
- Lead Sponsor
- John, George, M.D.
- Target Recruit Count
- 30
- Registration Number
- NCT01478256
- Locations
- 🇺🇸
George John, M.D., Louisville, Kentucky, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.